SternL.Hyaline membrane disease. Orlando FL: Grune and Stratton, 1984.
2.
RobertsonB.Pathology and pathophysiology of neonatal surfactant deficiency. In: RobertsonB, Van GoldeLMG, BatenburgJJ, eds. Pulmonary surfactant. Amsterdam: Elsevier Science Publishers, 1984:383–418.
3.
AdamsFH, FujiwaraT, EmmanouilidesG.Lung phospholipid of the human fetus and infants with and without hyaline membrane disease. J Pediatr1970;77:833–841.
4.
HallmanM, MerrittTA, PohjavuoriM, GluckL.Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res1986;20:1228–1235.
5.
JobeA, IkegamiM.Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis1987;136:1256–1275.
6.
JobeA, IkegamiM, JacobsH, JonesS.Surfactant pool sizes and severity of RDS in prematurely delivered lambs. Am Rev Respir Dis1983;127:751–755.
7.
IkegamiM, JobeA, YamadaT, SeidnerS.Relationship between alveolar saturated phosphatidylcholine pool sizes and compliance of preterm rabbit lungs. Am Rev Respir Dis1989;139:367–369.
8.
IkegamiM, JacobsH, JobeA.Surfactant function in respiratory distress syndrome. J Pediatr1983;102:443–447.
9.
IkegamiM, JobeAH, GlatzT.Surface activity following natural surfactant treatment in premature lambs. J Appl Physiol1981;51:306–312.
10.
SeegerW, StohrG, WolfHRD, NeuhofH.Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol1985;58:326–338.
11.
JacksonJC, MacKenzieAP, ChiEY, StandaertTA, TruogWE, HodsonWA. Mechanisms for reduced total lung capacity at birth and during hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis1990;142:413–419.
12.
JobeA, IkegamiM, JacobsH, JonesS, ConwayD.Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol1983;55:169–176.
13.
JobeA, JacobsH, IkegamiM, BerryD.Lung protein leaks in ventilated lambs: Effect of gestational age. J Appl Physiol1985;58:1246–1251.
14.
IkegamiM, JobeA, PettenazzoA, SeidnerSR, BerryDD, RuffiniL.Effects of maternal treatment with corticosteroids, T3, TRH and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis1987;136:892–898.
15.
JacobsH, JobeA, IkegamiM, JonesS.Accumulation of alveolar surfactant following delivery and ventilation of premature lambs. Exp Lung Res1985;8:125–140.
16.
JobeA.Metabolism of endogenous surfactant and exogenous surfactants for replacement therapy. Seminars Perinatol1988;12:231–244.
17.
IkegamiM, JobeA, YamadaT, et al. Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol1989;67:429–437.
18.
JobeA, IkegamiM, JacobsH, JonesS.Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant. J Clin Invest1984;73:848–856.
19.
SeidnerS, PettenazzoA, IkegamiM, JobeA.Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol1988;64:2366–2371.
20.
IkegamiM, JobeA, SeidnerS, YamadaT.Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res1989;25:32–37.
21.
GrossmanG, NilssonR, RobertsonB.Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung: The prophylactic effect of surfactant replacement. Eur J Pediatr1986;145:361–367.
22.
MerrittTA, HallmanM, HolcombK, et al. Human surfactant treatment of severe respiratory distress syndrome: Pulmonary effluent indicators of lung inflammation. J Pediatr1986;108:741–748.
23.
JobeAH, IkegamiM, GlatzT, YoshidaY, DiakmanolisE, PadburyJ.Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest1981;67:370–375.
24.
VidyasagarD, MaetaH, RajuR, et al. Bovine surfactant (Surfactant-TA) therapy in immature baboons with hyaline membrane disease. Pediatrics1985;75:1132–1142.
25.
DavisJ, Veness-MeehanK, NotterR, BhutaniV, KendigJ, ShapiroD.Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. N Engl J Med1988;319:476–479.
26.
CouserR, FerraraB, EbertJ, HoekstraR, FangmanJ.Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr1990;116:119–124.
27.
EdburgKE, Ekstrom-JodalB, HallmanM, HjalmarsonO, SandbergK, SilbergerA.Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS. Acta Pediatr Scand1990;79:750–755.
EnhorningG.Artificial surfactant to prevent and treat neonatal respiratory distress syndrome. Pediatrics1980;66:799–800.
32.
ShapiroDL, NotterRH. Surfactant replacement therapy. New York: Alan R Liss Inc, 1989.
33.
Exosurf Neonatal-Product Monograph. Research Triangle Park NC: Burroughs Wellcome Co, 1990.
34.
Survanta Treatment Investigational New Drug Manual. Columbus OH: Ross Laboratories, 1989.
35.
HallmanM, MerrittTA, JarvenpaaA, et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial. J Pediatr1985;106:963–969.
36.
MerrittTA, HallmanM, BloomBT, et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med1986;315:785–790.
37.
DunnM, ShennanAT, PossmayerF.Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics1990;86:564–571.
38.
LongW, ThompsonT, SundellH, SchumacherR, VolbergF, GuthrieR, and the American Neonatal Exosurf Study Group I. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700-1350 gram infants with respiratory distress syndrome. J Pediatr1991;118:595–606.
39.
EnhorningG, ShennanA, PossmayerF, DunnM, ChenCP, MilliganJ.Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics1985;76:145–153.
40.
KwongMS, EaganEA, NotterRH, ShapiroDL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics1985;76:585–592.
41.
KendigJW, NotterRH, CoxC, et al. Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics1988;82:756–762.
42.
SollRF, HoekstraRE, FangmanJJ, et al. Ross Collaborative Surfactant Prevention Study Group. Multi-center trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics1990;85:1092–1102.
43.
GitlinJD, SollRF, ParadRB, et al. Randomized controlled trial of exogenous surfactant treatment of hyaline membrane disease. Pediatrics1987;79:31–37.
44.
RajuTN, VidyasagarD, BhatR, et al. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet1987;1:651–655.
45.
Collaboratory European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics1988;82:683–691.
46.
HorbarJD, SollRF, SutherlandJM, et al. A multicenter randomized placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med1989;320:959–965.
47.
LangMJ, HallRT, ReddyNS, KurthCG, MerrittTA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birthweight infants. J Pediatr1990;116:295–300.
48.
MorleyCJ, GreenoughA, MillerNG, et al. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23-34 weeks gestation. Early Human Devel1988;17:41–54.
49.
KonishiM, FujiwaraT, NaitoT, et al. Surfactant replacement therapy in neonatal respiratory distress syndrome. Eur J Pediatr1988;147:20–25.
50.
JobeAH. Lung maturational agents and surfactant treatments: Are they complementary in preterm infants?J Perinatol1989;9:1418.
51.
ThibeaultDW, BeattyECJr, HallRT, BowenSK, O'NeillDH. Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligohydramnios. J Pediatr1985;107:278–281.
52.
SwischukLE, RichardsonCJ, NicholsMM, IngmanMJ. Primary pulmonary hypoplasia in the neonate. J Pediatr1979;95:573–577.
53.
HislopA, WigglesworthJS, DesaiR.Alveolar development in the human fetus and infant. Early Hum Devel1986;13:1–11.
FujiwaraT, KonishiM, ChidaS, MaetaH.Factors affecting the response to a postnatal single dose of a reconstituted bovine surfactant (Surfactant TA). In: LachmanB, ed. Surfactant replacement therapy. Berlin: Springer-Verlag, 1988:91–107.
